Journal Home
Search for

Volume 60, Issue 1, Pages 110-119 (January 2009)


View previous. 29 of 52 View next.

Minimally invasive techniques in the treatment of saphenous varicose veins

Tamar Nijsten, MD, PhDaCorresponding Author Informationemail address, Renate R. van den Bosa, Mitchel P. Goldman, MDe, Michael A. Kockaert, MDa, Thomas M. Proebstle, MD, PhDb, Eberhard Rabe, MD, PhDc, Neil S. Sadick, MDf, Robert A. Weiss, MDd, Martino H.A. Neumann, MD, PhDa

published online 03 October 2008.

Lower extremity venous insufficiency is common and increases with age. In addition to classical symptoms, it may result in skin changes and venous ulcers. Chronic venous insufficiency has a great impact on patients' health-related quality of life and is associated with considerable health care costs. Surgical ligation of the junction with or without stripping has been the standard of care in the treatment of insufficient great and small saphenous veins. However, the recurrence rates are relatively high and surgery may be associated with serious adverse events and considerable down time; it is also cosmetically suboptimal. To improve efficacy, patients' health-related quality of life and treatment satisfaction and to reduce serious side effects, costs, and postoperative pain, several minimally invasive techniques have been introduced in the last decade. Dermatologists have played an important role in the development of these new therapies of truncal varicose veins. Of the new therapies, ultrasound-guided foam sclerotherapy, endovenous laser therapy, and radiofrequency ablation are the most common and challenge surgery as the “gold standard” of care for patients with varicose veins. The objective of this review is to inform clinicians about these 3 therapeutic options for truncal varicose veins and to describe and compare the procedures, indications, efficacy, and safety profile.

a Department of Dermatology, Erasmus MC Rotterdam, Rotterdam, The Netherlands

b Department of Dermatology, University of Mainz, Mainz, Germany

c Department of Dermatology, University of Bonn, Bonn, Germany

d Department of Dermatology, Johns Hopkins University, Baltimore, MD

e Department of Dermatology, University of California, San Diego and La Jolla Spa MD, San Diego, California

f Department of Dermatology, Weill Medical College, Cornell University, New York, NY

Corresponding Author InformationReprint requests: Tamar Nijsten, MD, PhD, Department of Dermatology, Erasmus MC, PO Box 2040, 3000 CA Rotterdam, The Netherlands.

 Funding sources: None.

 Conflicts of interest: None declared.

PII: S0190-9622(08)00937-7

doi:10.1016/j.jaad.2008.07.046


View previous. 29 of 52 View next.